Grandview Asset Management’s DexCom DXCM Stock Holding History

Grandview Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,833	Closed	-$213K	–	77
2023 Q1	$213K	Buy	+1,833	New	+$205K	0.13%	112
2022 Q2	–	Sell	-2,288	Closed	-$293K	–	129
2022 Q1	$293K	Hold	2,288	–	–	0.12%	119
2021 Q4	$307K	Buy	+2,288	New	+$329K	0.12%	118
2021 Q2	–	Sell	-17,404	Closed	-$1.56M	–	201
2021 Q1	$1.56M	Sell	17,404 -3,240	-16%	-$304K	0.83%	35
2020 Q4	$1.91M	Buy	20,644 +600	+3%	+$53.6K	1.25%	21
2020 Q3	$2.07M	Sell	20,044 -1,020	-5%	-$107K	1.68%	17
2020 Q2	$2.13M	Buy	+21,064	New	+$1.88M	1.86%	14
2020 Q1	–	Sell	-21,084	Closed	-$1.16M	–	32
2019 Q4	$1.16M	Sell	21,084 -2,340	-10%	-$111K	1.1%	24
2019 Q3	$872K	Sell	23,424 -260	-1%	-$10.1K	0.79%	33
2019 Q2	$887K	Sell	23,684 -7,932	-25%	-$249K	0.82%	35
2019 Q1	$941K	Buy	+31,616	New	+$1.11M	0.87%	35

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Grandview Asset Management's DXCM Position: Q2 2023 in Review

Grandview Asset Management sold out of DexCom (DXCM) in Q2 2023, closing a stake of 1,833 shares — an estimated $213K sold.

Grandview Asset Management first reported a position in DXCM in Q1 2019 and held it in 11 quarters. The position peaked at $2.13M in Q2 2020. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

Grandview Asset Management reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
Grandview Asset Management sold 1,833 DexCom shares in Q2 2023, an estimated $213K.
Grandview Asset Management first reported a position in DexCom in Q1 2019 and held it in 11 quarters.
Grandview Asset Management's DexCom position peaked at $2.13M in Q2 2020.
954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Grandview Asset Management's 13F filing for Q2 2023, filed 7 Jul 2023.